VIVIMEDLAB
Vivimed Labs Limited (VIVIMEDLAB) Stock Analysis
Vivimed Labs Limited manufactures APIs and specialty chemicals for pharma and personal-care industries. It supplies actives and intermediates from India to global customers with R&D support. The company has operations in multiple countries through subsidiaries. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - Specialty & Generic
₹5.50
-9.29% 1W | +12.70% 52W
Market Cap
45 CR
P/E Ratio
–
52W High
₹29.4
52W Low
₹4.8
Div. Yield
0%
Beta
0.8
50 DMA
₹5.7
200 DMA
₹7.4
Profit Margin
-231.3%
Inst. Own.
9.4%
📊 CONSOLIDATION
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 37 | 35 | 34 | 41 | 39 | 29 | 25 | 37 | 26 | 21 | 21 | 16 | 12 |
| Expenses | 201 | 36 | 40 | 40 | 67 | 40 | 25 | 35 | 28 | 22 | 22 | 27 | 152 |
| Operating Profit | -164 | -0 | -6 | 1 | -28 | -11 | -1 | 1 | -2 | -0 | -1 | -11 | -140 |
| OPM % | -444% | -0.9% | -18% | 3.1% | -74% | -37% | -2.6% | 2.9% | -10% | -1.3% | -4.6% | -68% | -1,169% |
| Other Income | 1 | 0 | 2 | 0 | 8 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 6 |
| Interest | 9 | 11 | 12 | 13 | -33 | 0 | 0 | 0 | 2 | 1 | 2 | 1 | 1 |
| Depreciation | 96 | 5 | 5 | 5 | 6 | 4 | 4 | 7 | 6 | 5 | 5 | 5 | 12 |
| Profit before tax | -268 | -16 | -20 | -17 | 7 | -15 | -5 | -6 | -5 | -5 | -7 | -17 | -147 |
| Tax % | -1% | 0% | 0% | -3% | 21% | 0% | 0% | 0% | 2% | 0% | 0% | 0% | 0% |
| Net Profit | -266 | -16 | -20 | -16 | 5 | -15 | -5 | -6 | -6 | -5 | -7 | -17 | -147 |
| EPS in Rs | -32.08 | -1.88 | -2.45 | -1.94 | 0.63 | -1.84 | -0.62 | -0.72 | -0.68 | -0.66 | -0.88 | -2.00 | -17.74 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,380 | 1,346 | 1,462 | 1,186 | 1,315 | 1,059 | 861 | 237 | 187 | 149 | 116 | 70 |
| Expenses | 1,156 | 1,111 | 1,057 | 971 | 1,135 | 1,049 | 830 | 245 | 374 | 182 | 129 | 222 |
| Operating Profit | 224 | 234 | 404 | 215 | 180 | 10 | 32 | -8 | -187 | -33 | -13 | -152 |
| OPM % | 16% | 17% | 28% | 18% | 14% | 1.0% | 3.7% | -3.3% | -100% | -22% | -11% | -218% |
| Other Income | 6 | 11 | 8 | 10 | 23 | 8 | 10 | 1 | 1 | 10 | 4 | 6 |
| Interest | 86 | 84 | 68 | 82 | 70 | 61 | 56 | 40 | 36 | 3 | 3 | 4 |
| Depreciation | 66 | 61 | 58 | 56 | 67 | 67 | 56 | 18 | 108 | 20 | 20 | 26 |
| Profit before tax | 78 | 100 | 286 | 86 | 66 | -109 | -70 | -65 | -331 | -46 | -32 | -176 |
| Tax % | 7% | 16% | 25% | 11% | 13% | -0% | 3% | 4% | -1% | -1% | 0% | 0% |
| Net Profit | 72 | 84 | 214 | 76 | 57 | -109 | -72 | -68 | -329 | -45 | -32 | -176 |
| EPS in Rs | 8.90 | 10.33 | 26.41 | 9.44 | 6.95 | -13.16 | -8.67 | -8.16 | -39.62 | -5.48 | -3.85 | -21.28 |
| Dividend Payout % | 0% | 0% | 2% | 4% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | -28.0% | -39.0% | -26.0% |
| Profit CAGR | 14.0% | – | – |
Shareholding Pattern
Promoters20.94%
FIIs1.64%
Public77.30%
Promoters7.76%
FIIs1.64%
Public90.47%
Promoters7.76%
FIIs1.64%
Public90.47%
Promoters7.76%
FIIs1.64%
Public90.47%
Promoters7.57%
FIIs1.64%
Public90.66%
Promoters21.98%
FIIs1.64%
Public76.27%
Promoters20.94%
FIIs1.64%
Public77.30%
Promoters20.94%
FIIs1.64%
Public77.29%
Promoters20.94%
FIIs1.64%
Public77.30%
Promoters7.57%
FIIs1.64%
Public90.66%
VIVIMEDLAB
Holdings Analysis
Key strengths & risk signals
42
Overall
26
Fundamental
59
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
WEAK POSITION! Current price (5.5) is below both moving averages.
WEAK! Trading at 2.8% of 52W range - near yearly lows.
WEAK MOMENTUM! Limited price growth - -9.3% (1 week), 6.2% (1 month), -7.5% (3 months).
Strengths (3)
BULLISH SENTIMENT! In last 30 days: 9 up days, 21 down days. Avg volume on up days: 95,912 vs down days: 73,624. Ratio: 1.3x
APPROACHING OVERSOLD! RSI at 37.1 - watch for reversal.
BELOW MARKET! Beta of 0.80 - slightly less volatile than market.
Fundamental & Technical Analysis
42Overall
26Fundamental
59Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: -27.9% (DECLINING, 2/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! -231.3% profit margin - thin profits.
PEG Valuation
0/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
5/20
TOO MUCH PUBLIC HOLDING! 77.3% public ownership - higher volatility risk.
Stability Index
2/10
CAUTION! Company made loss in last quarter. Be careful.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (5.7) is below 200-day average (7.4) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (5.5) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
6/10
POSITIVE YEAR! Stock gained 12.7% in the last year.
Volume Sentiment
25/30
BULLISH SENTIMENT! In last 30 days: 9 up days, 21 down days. Avg volume on up days: 95,912 vs down days: 73,624. Ratio: 1.3x
RSI
4/5
APPROACHING OVERSOLD! RSI at 37.1 - watch for reversal.
52W Range
1/5
WEAK! Trading at 2.8% of 52W range - near yearly lows.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - -9.3% (1 week), 6.2% (1 month), -7.5% (3 months).
Beta
4/5
BELOW MARKET! Beta of 0.80 - slightly less volatile than market.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VIVIMEDLAB | ₹5.50 | – | -231.3% | -27.9% | – | +12.7% | 42 | BREAKDOWN | +2,526.8% | +786.1% | -53.1% | -25.0% |
| MANGALAM | ₹32.60 | – | -16.5% | -14.3% | – | -54.4% | 44 | CONSOLIDATION | -44.9% | -43.3% | -0.2% | -15.2% |
| BIOFILCHEM | ₹32.60 | 108.7 | 1.4% | -1.9% | 70.7% | -23.4% | 54 | HIT RESISTANCE | -95.8% | -50.0% | +93.8% | +63.2% |
| LASA | ₹5.90 | – | -253.8% | -42.1% | – | -50.5% | 40 | BREAKDOWN | -82.9% | -14.3% | -94.0% | -1,300.0% |
| ORTINGLOBE | ₹15.60 | – | – | -74.4% | – | +31.9% | 52 | APPROACHING SUPPORT | +50.0% | – | – | – |
| VAISHALI | ₹8.20 | – | 4.1% | 18.0% | -15.2% | -27.4% | 57 | CONSOLIDATION | – | +278.0% | – | -15.0% |
| KREBSBIO | ₹56.00 | – | -55.9% | -23.1% | – | -28.3% | 49 | CONSOLIDATION | -52.8% | +8.7% | +27.3% | +2.9% |
| ALPA | ₹59.50 | 29.2 | 3.8% | 4.3% | 6.1% | -37.0% | 46 | APPROACHING SUPPORT | -91.5% | -28.6% | +25.1% | -23.9% |
Data from TradeAlone · Updated daily
No news tagged for VIVIMEDLAB yet.
